NEVPF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 23 closing price
Capitalization
45.13M
THAR
Price
$4.77
Change
-$0.43 (-8.27%)
Updated
Sep 3 closing price
Capitalization
25.29M
Interact to see
Advertisement

NEVPF vs THAR

Header iconNEVPF vs THAR Comparison
Open Charts NEVPF vs THARBanner chart's image
Abliva AB
Price$0.03
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
Tharimmune
Price$4.77
Change-$0.43 (-8.27%)
Volume$1.29M
Capitalization25.29M
NEVPF vs THAR Comparison Chart in %
Loading...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEVPF vs. THAR commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEVPF is a StrongBuy and THAR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (NEVPF: $0.03 vs. THAR: $4.77)
Brand notoriety: NEVPF and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NEVPF: 100% vs. THAR: 10%
Market capitalization -- NEVPF: $45.13M vs. THAR: $25.29M
NEVPF [@Biotechnology] is valued at $45.13M. THAR’s [@Biotechnology] market capitalization is $25.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEVPF’s FA Score shows that 0 FA rating(s) are green whileTHAR’s FA Score has 0 green FA rating(s).

  • NEVPF’s FA Score: 0 green, 5 red.
  • THAR’s FA Score: 0 green, 5 red.
According to our system of comparison, both NEVPF and THAR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

THAR’s TA Score shows that 6 TA indicator(s) are bullish.

  • THAR’s TA Score: 6 bullish, 5 bearish.

Price Growth

NEVPF (@Biotechnology) experienced а 0.00% price change this week, while THAR (@Biotechnology) price change was -3.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEVPF($45.1M) has a higher market cap than THAR($25.3M). THAR YTD gains are higher at: 134.975 vs. NEVPF (-22.222). THAR has higher annual earnings (EBITDA): -11.99M vs. NEVPF (-87.99M). NEVPF has more cash in the bank: 32.7M vs. THAR (2.24M). NEVPF (0) and THAR (0) have equivalent revenues.
NEVPFTHARNEVPF / THAR
Capitalization45.1M25.3M178%
EBITDA-87.99M-11.99M734%
Gain YTD-22.222134.975-16%
P/E RatioN/A0.02-
Revenue00-
Total Cash32.7M2.24M1,459%
Total DebtN/A250K-
FUNDAMENTALS RATINGS
NEVPF: Fundamental Ratings
NEVPF
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
18

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NEVPFTHAR
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
66%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
15%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
14%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSR58.870.53
+0.91%
Centerspace
LYEL11.430.02
+0.18%
Lyell Immunopharma Inc
YOSH1.71N/A
N/A
Yoshiharu Global Co
VCTR70.58-0.44
-0.62%
Victory Capital Holdings
NXPI228.20-4.46
-1.92%
NXP Semiconductors NV

NEVPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEVPF has been loosely correlated with CELC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NEVPF jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEVPF
1D Price
Change %
NEVPF100%
N/A
CELC - NEVPF
61%
Loosely correlated
+1.16%
ADAP - NEVPF
56%
Loosely correlated
-9.00%
YMAB - NEVPF
56%
Loosely correlated
+0.23%
VYNE - NEVPF
52%
Loosely correlated
-1.55%
THAR - NEVPF
51%
Loosely correlated
-8.27%
More

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
-8.27%
CDTX - THAR
82%
Closely correlated
-0.56%
RNAC - THAR
81%
Closely correlated
+4.17%
NCNA - THAR
81%
Closely correlated
+2.01%
TAOX - THAR
79%
Closely correlated
-3.38%
JAGX - THAR
79%
Closely correlated
+0.60%
More